CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Cash flows from operating activities:
Net income (loss)	$ 77,291	$ (244,603)
Adjustments to net income (loss):
Depreciation and amortization	322,729	326,374
Deferred income tax expense (benefit)	12,135	3,775
Impairments and other charges	5,318
Amortization of debt discount and deferred financing costs	4,239	6,029
Losses (gains) on debt buyback	(25,098)	(372)
Losses (gains) on long-lived assets, net	927	(3,522)
Losses (gains) on investments, net	(960)	518
Share-based compensation	8,321	7,829
Foreign currency transaction losses (gains), net	16,810	(3,178)
Mark-to-market (gain) loss on warrants	(52,466)	93,766
Noncontrolling interest	(23,456)	(22,810)
Other	98	150
Changes in operating assets and liabilities, net of effects from acquisitions:
Accounts receivable	27,461	(3,650)
Inventory	(24,125)	5,734
Other current assets	(5,595)	(10,445)
Other long-term assets	(6,373)	(819)
Trade accounts payable and accrued liabilities	(44,506)	(5,130)
Income taxes payable	1,896	(4,095)
Other long-term liabilities	27,870	16,599
Net cash provided by (used for) operating activities	322,516	162,150
Cash flows from investing activities:
Purchases of investments	(24,551)	(18,741)
Capital expenditures	(263,485)	(160,890)
Proceeds from sales of assets	5,050	16,431
Other	12	39
Net cash (used for) provided by investing activities	(282,974)	(163,161)
Cash flows from financing activities:
Proceeds from issuance of long-term debt	250,000
Reduction in long-term debt	(292,853)	(109,965)
Debt issuance costs	(8,036)	(3,858)
Proceeds from revolving credit facilities	125,000	130,000
Reduction in revolving credit facilities	(125,000)	(590,000)
Proceeds from issuance of common shares, net of issuance costs		3,767
Payments for employee taxes on net settlement of equity awards	(7,079)	(4,523)
Dividends to common and preferred shareholders	(194)	(65)
Distributions to noncontrolling interest	(2,269)	(3,489)
Distribution of trust account for special purpose acquisition company	(186,933)
Other		(445)
Net cash (used for) provided by financing activities	(247,364)	(578,578)
Effect of exchange rate changes on cash and cash equivalents	(8,641)	1,431
Net increase (decrease) in cash and cash equivalents and restricted cash	(216,463)	(578,158)
Cash and cash equivalents and restricted cash, beginning of period	737,140	1,273,510
Cash and cash equivalents and restricted cash, end of period	520,677	695,352
RECONCILIATION OF CASH AND CASH EQUIVALENTS AND RESTRICTED CASH
Cash and cash equivalents, beginning of period	451,025	991,471
Restricted cash, beginning of period	286,115	282,039
Cash and cash equivalents and restricted cash, beginning of period	737,140	1,273,510
Cash and cash equivalents, end of period	413,376	412,979
Restricted cash, end of period	$ 107,301	$ 282,373
Restricted cash, Balance Sheet location	Restricted cash held in trust	Restricted cash held in trust
Cash and cash equivalents and restricted cash, end of period	$ 520,677	$ 695,352